Ras-MAPK signaling in osteogenic differentiation: Friend or foe?

Journal of Bone and Mineral Research

Volumn 21, Issue 9, 2006, Pages 1331-1338

  Schindeler, Aaron ^a,b   Little, David G ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; COLLAGEN TYPE 1; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; FOCAL ADHESION KINASE; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROFIBROMIN; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SERINE THREONINE KINASE; RAC PROTEIN; RAF PROTEIN; RAL PROTEIN; RAS PROTEIN; SCATTER FACTOR; SIALOPROTEIN; SMAD PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG;

BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL LINE; CELL TYPE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; MESENCHYMAL STEM CELL; MESENCHYME; NONHUMAN; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; OSSIFICATION; OSTEOBLAST; REVIEW;

ANIMALS; BONE MORPHOGENETIC PROTEINS; GENES, RAS; HUMANS; MAP KINASE SIGNALING SYSTEM; OSTEOGENESIS; OSTEOLYSIS; SIGNAL TRANSDUCTION;

EID: 33748028794     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.060603     Document Type: Review

References (57)

1. Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ, Der CJ 1998 Increasing complexity of Ras signaling. Oncogene 17:1395-1413.
2. Vojtek AB, Der CJ 1998 Increasing complexity of the Ras signaling pathway. J Biol Chem 273:19925-19928.
3. Mitin N, Rossman KL, Der CJ 2005 Signaling interplay in Ras superfamily function. Curr Biol 15:R563-R574.
4. Ory S, Morrison DK 2004 Signal transduction: Implications for Ras-dependent ERK signaling. Curr Biol 14:R277-R278.
5. Hancock JF 2003 Ras proteins: Different signals from different locations. Nat Rev Mol Cell Biol 4:373-384.
6. Goodwin JS, Drake KR, Rogers C, Wright L, Lippincott-Schwartz J, Philips MR, Kenworthy AK 2005 Depalmitoylated Ras traffics to and from the Golgi complex via a nonvesicular pathway. J Cell Biol 170:261-272.
7. Seger R, Krebs EG 1995 The MAPK signaling cascade. FASEB J 9:726-735.
8. Zhang W, Liu HT 2002 MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12:9-18.
9. Kitching R, Qi S, Li V, Raouf A, Vary CP, Seth A 2002 Coordinate gene expression patterns during osteoblast maturation and retinoic acid treatment of MC3T3-E1 cells. J Bone Miner Metab 20:269-280.
10. Yamaguchi A, Komori T, Suda T 2000 Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 21:393-411.
11. Nohe A, Keating E, Knaus P, Petersen NO 2004 Signal transduction of bone morphogenetic protein receptors. Cell Signal 16:291-299.
12. ten Dijke P, Fu J, Schaap P, Roelen BA 2003 Signal transduction of bone morphogenetic proteins in osteoblast differentiation. J Bone Joint Surg Am 85(Suppl 3):34-38.
13. Westendorf JJ, Kahler RA, Schroeder TM 2004 Wnt signaling in osteoblasts and bone diseases. Gene 341:19-39.
14. Rawadi G, Vayssiere B, Dunn F, Baron R, Roman-Roman S 2003 BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 18:1842-1853.
15. Golden LH, Insogna KL 2004 The expanding role of PI3-kinase in bone. Bone 34:3-12.
16. Ghosh-Choudhury N, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, Choudhury GG 2002 Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem 277:33361-33368.
17. Osyczka AM, Leboy PS 2005 Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. Endocrinology 146:3428-3437.
18. Lee KS, Hong SH, Bae SC 2002 Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene 21:7156-7163.
19. Kozawa O, Hatakeyama D, Uematsu T 2002 Divergent regulation by p44/p42 MAP kinase and p38 MAP kinase of bone morphogenetic protein-4-stimulated osteocalcin synthesis in osteoblasts. J Cell Biochem 84:583-589.
20. Noth U, Tuli R, Seghatoleslami R, Howard M, Shah A, Hall DJ, Hickok NJ, Tuan RS 2003 Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Exp Cell Res 291:201-211.
21. Suzawa M, Tamura Y, Fukumoto S, Miyazono K, Fujita T, Kato S, Takeuchi Y 2002 Stimulation of Smad1 transcriptional activity by Ras-extracellular signal-regulated kinase pathway: A possible mechanism for collagen-dependent osteoblastic differentiation. J Bone Miner Res 17:240-248.
22. Tamura Y, Takeuchi Y, Suzawa M, Fukumoto S, Kato M, Miyazono K, Fujita T 2001 Focal adhesion kinase activity is required for bone morphogenetic protein-Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells. J Bone Miner Res 16:1772-1779.
23. Kretzschmar M, Doody J, Massague J 1997 Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature 389:618-622.
24. Kretzschmar M, Doody J, Timokhina I, Massague J 1999 A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras. Genes Dev 13:804-816.
25. Lakkis MM, Tennekoon GI 2000 Neurofibromatosis type 1. I. General overview. J Neurosci Res 62:755-763.
26. Vitale MG, Guha A, Skaggs DL 2002 Orthopaedic manifestations of neurofibromatosis in children: An update. Clin Orthop Relat Res 401:107-118.
27. Kuorilehto T, Poyhonen M, Bloigu R, Heikkinen J, Vaananen K, Peltonen J 2005 Decreased bone mineral density and content in neurofibromatosis type 1: Lowest local values are located in the load-carrying parts of the body. Osteoporos Int 16:928-936.
28. Lammert M, Kappler M, Mautner VF, Lammert K, Storkel S, Friedman JM, Atkins D 2005 Decreased bone mineral density in patients with neurofibromatosis 1. Osteoporos Int 16:1161-1166.
29. Kuorilehto T, Nissinen M, Koivunen J, Benson MD, Peltonen J 2004 NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos. J Bone Miner Res 19:983-989.
30. Yu X, Chen S, Potter OL, Murthy SM, Li J, Pulcini JM, Ohashi N, Winata T, Everett ET, Ingram D, Clapp WD, Hock JM 2005 Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning. Bone 36:793-802.
31. Schindeler A, Ramachandran M, Little DG 2006 BMP-2 treatment produces an attenuated response in a mouse model of type 1 neurofibromatosis. Bone 38(Suppl 1):18.
32. Klein BY, Rojansky N, Gal I, Shlomai Z, Liebergall M, Ben Bassat H 1995 Analysis of cell-mediated mineralization in culture of bone-derived embryonic cells with neurofibromatosis. J Cell Biochem 57:530-542.
33. Nakayama K, Tamura Y, Suzawa M, Harada S, Fukumoto S, Kato M, Miyazono K, Rodan GA, Takeuchi Y, Fujita T 2003 Receptor tyrosine kinases inhibit bone morphogenetic protein-Smad responsive promoter activity and differentiation of murine MC3T3-E1 osteoblast-like cells. J Bone Miner Res 18:827-835.
34. Higuchi C, Myoui A, Hashimoto N, Kuriyama K, Yoshioka K, Yoshikawa H, Itoh K 2002 Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix. J Bone Miner Res 17:1785-1794.
35. Hu Y, Chan E, Wang SX, Li B 2003 Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation. Endocrinology 144:2068-2074.
36. Dunford JE, Thompson K, Coxon FP, Luckman SP, Hahn FM, Poulter CD, Ebetino FH, Rogers MJ 2001 Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther 296:235-242.
37. Luckman SP, Coxon FP, Ebetino FH, Russell RG, Rogers MJ 1998 Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: Evidence from structure-activity relationships in J774 macrophages. J Bone Miner Res 13:1668-1678.
38. Liao JK, Laufs U 2005 Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45:89-118.
39. Im GI, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS 2004 Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 25:4105-4115.
40. Pan B, To LB, Farrugia AN, Findlay DM, Green J, Gronthos S, Evdokiou A, Lynch K, Atkins GJ, Zannettino AC 2004 The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro. Bone 34:112-123.
41. Yu J, Chang SS, Suratwala S, Chung WS, Abdelmessieh P, Lee HJ, Yang J, Lee FY 2005 Zoledronate induces apoptosis in cells from fibro-cellular membrane of unicameral bone cyst (UBC). J Orthop Res 23:1004-1012.
42. Maeda T, Matsunuma A, Kawane T, Horiuchi N 2001 Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun 280:874-877.
43. Li X, Cui Q, Kao C, Wang GJ, Balian G 2003 Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone 33:652-659.
44. Chen C, Koh AJ, Datta NS, Zhang J, Keller ET, Xiao G, Franceschi RT, D'Silva NJ, McCauley LK 2004 Impact of the mitogen-activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts. J Biol Chem 279:29121-29129.
45. Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT 2002 Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 17:101-110.
46. Xiao G, Jiang D, Thomas P, Benson MD, Guan K, Karsenty G, Franceschi RT 2000 MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J Biol Chem 275:4453-4459.
47. Maeda T, Matsunuma A, Kurahashi I, Yanagawa T, Yoshida H, Horiuchi N 2004 Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. J Cell Biochem 92:458-471.
48. Dang ZC, Lowik CW 2004 Differential effects of PD98059 and U0126 on osteogenesis and adipogenesis. J Cell Biochem 92:525-533.
49. Lou J, Tu Y, Li S, Manske PR 2000 Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2. Biochem Biophys Res Commun 268:757-762.
50. Wang FS, Wang CJ, Huang HJ, Chung H, Chen RF, Yang KD 2001 Physical shock wave mediates membrane hyperpolarization and Ras activation for osteogenesis in human bone marrow stromal cells. Biochem Biophys Res Commun 287:648-655.
51. Lai CF, Chaudhary L, Fausto A, Halstead LR, Ory DS, Avioli LV, Cheng SL 2001 Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 276:14443-14450.
52. Mehrotra M, Krane SM, Walters K, Pilbeam C 2004 Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells. J Cell Biochem 93:741-752.
53. Fakhry A, Ratisoontorn C, Vedhachalam C, Salhab I, Koyama E, Leboy P, Pacifici M, Kirschner RE, Nah HD 2005 Effects of FGF-2/-9 in calvarial bone cell cultures: Differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential. Bone 36:254-266.
54. Jaiswal RK, Jaiswal N, Bruder SP, Mbalaviele G, Marshak DR, Pittenger MF 2000 Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem 275:9645-9652.
55. Celil AB, Campbell PG 2005 BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J Biol Chem 280:31353-31359.
56. Xiao G, Jiang D, Gopalakrishnan R, Franceschi RT 2002 Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J Biol Chem 277:36181-36187.
57. Yue J, Frey RS, Mulder KM 1999 Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFbeta. Oncogene 18:2033-2037.